Synaptic Transmission Between Neurons


Early in the last century, Ramón y Cajal and others used the Golgi stain to demonstrate that the nervous system is a collection of individual neurons (e.g., see Fig. 1.16A ) rather than a vast syncytial network, as some had alleged. An obvious corollary of this demonstration is that neurons must have mechanisms by which they communicate with one another. Although there are some instances in which neurons are directly coupled, allowing ionic currents to flow from one into another (discussed at the end of this chapter), in most cases neurons communicate with one another by releasing neuroactive chemical transmitters, typically at specialized sites called synapses. a

a The term synapse started out as a noun, derived from two Greek words meaning “to fasten together.” It is now also used commonly as a verb, referring to one neuron making a synaptic contact with another.

The first insights into how synapses between neurons may work came from studies of the neuromuscular junction. There the endings of motor neurons release a small-molecule transmitter (acetylcholine), which diffuses across the cleft between neuronal ending and muscle fiber, attaches to receptor molecules in the muscle fiber membrane, and initiates permeability changes and consequent rapid depolarization ( Fig. 8.1 ; see also Figs. 8.10 and 8.11 ). The depolarization is short lived because an enzyme (acetylcholinesterase) simultaneously competes for acetylcholine and hydrolyzes it, making acetylcholine inactive. The neuromuscular junction is representative of only one type of synaptic interaction. Several dozen neurotransmitters have been described. Some are small molecules such as acetylcholine (see Figs. 8.18, 8.19, and 8.21 to 8.23 ), whereas others are larger peptide molecules or diffusible gases; some produce brief depolarizing or hyperpolarizing changes in membrane potential, whereas others produce prolonged potential changes ( Fig. 8.2 ) or changes in membrane properties that last for days or longer. b

b Alternative terms such as neuromodulator or neurohormone are used by many authors to refer to neuroactive substances that have long-lasting effects or that diffuse from sites that are not typical synapses. However, there is not yet general agreement on how these terms should be defined, and a number of intermediate cases are known. Therefore, for the sake of simplicity, all such molecules are referred to as neurotransmitters in this chapter.

Fig. 8.1
General arrangement of a neuromuscular junction (see Fig. 8.11 for a scanning electron micrograph of a real junction). A motor axon loses its myelin sheath and divides into several terminal branches (At) covered by processes of Schwann cells ( Sc; not indicated in the upper drawing). Each terminal contains a series of clusters of vesicles (V) filled with acetylcholine. Invasion of a terminal by an action potential causes some of the vesicles to merge with the terminal membrane and dump their contents into the cleft between the terminal and the muscle fiber. The liberated acetylcholine diffuses across the cleft and through the basal lamina (BL) and reaches acetylcholine receptor molecules (AChR) at the entrance to troughs in the muscle surface across from each vesicle cluster. These acetylcholine receptors are ligand-gated cation channels, and binding acetylcholine causes depolarization of the muscle fiber (see Fig. 8.10 ). The action of acetylcholine is temporally limited by the enzyme acetylcholinesterase, associated with the basal lamina, which competes for and hydrolyzes acetylcholine.

Fig. 8.2
Schematic overview of the electrical events at typical chemical synapses. Action potentials (1) spread electrotonically into axon terminals (2) and cause the release of neurotransmitter molecules. Neurotransmitter then diffuses to postsynaptic membranes and elicits electrical responses determined by postsynaptic receptors; these include brief depolarizing (3) and hyperpolarizing (4) responses as well as slower responses, either preceded by a brief response (5) or not (6). The release and diffusion of neurotransmitter take hundreds of microseconds or longer, and as a result, postsynaptic signals are delayed slightly.

There Are Five Steps in Conventional Chemical Synaptic Transmission

Chemical synapses come in a variety of shapes and sizes, but they all include as their essential components a presynaptic ending and a postsynaptic element, separated by a 10- to 20-nm synaptic cleft (see Fig. 1.21 ). The presynaptic elements are usually either terminal expansions of axons (see Fig. 8.2 ) or expansions of axons as they pass by other neuronal elements (referred to as boutons terminaux and boutons en passage, respectively—French for “terminal buttons” and “buttons along the way”). In some instances, however, dendrites or even parts of neuronal cell bodies can be presynaptic elements. Similarly, the postsynaptic element is usually part of the surface of a dendrite, but alternatively, it can be located on a cell body, axon initial segment, or another synaptic terminal ( Fig. 8.3 ; see also Fig. 1.22 ). All these locations have functional implications, as described later in this chapter.

Fig. 8.3, Synapses densely distributed over the surface of hippocampal neurons developing in tissue culture. The cell bodies and dendrites were stained with a fluorescent antibody directed against MAP2, a microtubule-associated protein restricted to the perikaryal-dendritic region of neurons (green fluorescence). Axon terminal projections originating from other neurons not visible in this field form a dense network of synaptic contact sites and were stained with a fluorescent antibody directed against synaptotagmin (red fluorescence), an integral membrane protein of synaptic vesicles. Overlapping red and green fluorescence, from sites where an axon terminal is superimposed on part of a dendrite, appears yellow.

The presynaptic and postsynaptic elements are the principal sites involved in the five essential components of conventional chemical synaptic transmission:

  • 1.

    Synthesis of neurotransmitter

  • 2.

    Concentration and packaging of neurotransmitter in the presynaptic element in preparation for its release

  • 3.

    Release of neurotransmitter from the presynaptic element into the synaptic cleft

  • 4.

    Binding of neurotransmitter to receptor molecules embedded in postsynaptic membranes

  • 5.

    Termination of neurotransmitter action

Although portions of the membranes of presynaptic and postsynaptic elements appear thickened, called the active zone (as presynaptic and postsynaptic densities that contain parts of the release mechanism and most of the receptors, respectively), the presynaptic element is distinguished by the presence of a swarm of neurotransmitter-filled synaptic vesicles. This anatomical asymmetry corresponds to the functional unidirectionality of synaptic transmission: in response to depolarization, the presynaptic ending releases the neurotransmitter contents of one or more vesicles, the transmitter diffuses across the synaptic cleft and binds to receptor molecules embedded in the postsynaptic membrane, and the postsynaptic neuron responds in some way. However, as described later in this chapter, chemical messages can also move in a retrograde direction across synapses.

Neurotransmitters Are Synthesized in Presynaptic Endings and in Neuronal Cell Bodies

Nearly all known or suspected neurotransmitters fall into one of two general categories: some are small molecules such as amines or amino acids, and the others are larger peptides (neuropeptides) or modified lipids. Small-molecule transmitters are synthesized in presynaptic cytoplasm, using locally available substrates (e.g., acetate and choline) and soluble enzymes that arrive by slow axonal transport ( Fig. 8.4A ). Making peptide transmitters, in contrast, requires the protein synthesis machinery that resides in the neuronal cell body. Neuropeptides start out there as larger precursor proteins that are packed into vesicles and dispatched by fast axonal transport to synaptic endings. Along the way, the precursors are cleaved and processed into the final, biologically active neuropeptides (see Fig. 8.4B ).

Fig. 8.4, Life cycles of small-molecule neurotransmitters (A) and neuropeptides (B). (A) Enzymes required for the synthesis and packaging of small-molecule neurotransmitters are themselves synthesized in the cell body (1), released from the Golgi apparatus (2), and conveyed to presynaptic terminals by slow axonal transport (3). The neurotransmitters are then synthesized from substrates transported into the terminals (4) and concentrated in vesicles (5) that were either recycled from the presynaptic membrane (6) or assembled from components transported from the cell body. (B) Precursors of neuropeptides are synthesized in the cell body (1) and packaged in the Golgi apparatus into vesicles (2), which are conveyed to presynaptic terminals by fast axonal transport along microtubules (3). Either in the cell body or during the journey down the axon, the precursor proteins are modified and become neuropeptides (4). After exocytosis, the membranes of large, dense-core vesicles are returned to the cell body for recycling (5).

Neurotransmitters Are Packaged Into Synaptic Vesicles Before Release

Synaptic vesicles are the units of currency at chemical synapses, the sites where neurotransmitters are packaged, concentrated, and protected from catabolism while awaiting release. All presynaptic endings contain small vesicles (about 40 nm), and many also contain less numerous but larger vesicles (≥100 nm). Depending on the preparation conditions used for electron microscopy, some of the small vesicles may appear dark, and others may look clear and either round or flattened; each large vesicle contains a dark core ( Fig. 8.5 ). These differences in appearance correspond to differences in neurotransmitter content. For example, endings with clear, flattened vesicles usually contain neurotransmitters that more likely will result in inhibitory effects on the postsynaptic cell.

Fig. 8.5, Types of synaptic vesicles in axon terminals (At) making synaptic contact with transversely sectioned dendrites (D) in the anterior horn of rat spinal cord. Two of the terminals (At1) contain clear, round vesicles; one (At2) contains clear, flattened vesicles; and one (At3) contains a mixture of small, round vesicles and large, dense-cored vesicles. The actual size of the dendrite in the center of the micrograph is about 2.5 × 1.5 µm.

Small synaptic vesicles contain small-molecule transmitters, concentrated to levels far beyond that found in the cytoplasm by specific transporters in the vesicle walls. Large dense-core vesicles contain neuropeptides at lower concentrations and may contain one or more small-molecule transmitters as well. The two kinds of vesicle, like the different neurotransmitters, are manufactured and recycled differently (see Fig. 8.4 ). Small-molecule transmitters are synthesized by cytoplasmic enzymes and can therefore be manufactured and packaged for release in individual synaptic endings. Small synaptic vesicles can therefore be recycled entirely within a presynaptic ending, whereas large dense-core vesicles must be created anew in the cell body. Modified lipid neurotransmitters do not use vesicles but are stored and released directly from the lipid membrane upon activation of enzymes.

Presynaptic Endings Release Neurotransmitters Into the Synaptic Cleft

Release of vesicle containing neurotransmitter is a Ca 2+ -mediated secretory process. Each presynaptic density, or active zone, contains an abundance of voltage-gated Ca 2+ channels, together with anchoring sites for a cluster of small vesicles that are held there (“docked”) by a Ca 2+ -sensitive system of proteins. Depolarization of the presynaptic terminal, such as by propagation of an action potential down the axon and subsequent electrotonic spread into the terminal, causes opening of the voltage-gated Ca 2+ channels. Because the free intracellular Ca 2+ concentration is only about 10 −7 M, Ca 2+ ions flow in through these channels and momentarily elevate the Ca 2+ concentration near the active zone by as much as 1000-fold. During the brief period before the excess Ca 2+ diffuses away or is sequestered, a vesicle docked nearby may fuse with the presynaptic membrane and discharge its contents into the synaptic cleft in a process called exocytosis ( Fig. 8.6A ). The whole process, from the arrival of an action potential to the release of a small vesicle's contents, can take less than 100 µsec. Because the large, dense-cored vesicles are not located adjacent to active zones, repetitive action potentials, additional Ca 2+ entry, and more time (tens of milliseconds) are typically required for their exocytosis (see Fig. 8.6B ). This exocytotic addition of membrane clearly cannot continue for very long, or else presynaptic endings would expand continuously. In fact, vesicle membranes are taken back up (by endocytosis ), and those used for small-molecule transmitters can be recycled in less than a minute (see Fig. 8.4A ).

Fig. 8.6, Ca 2+ -triggered release of neurotransmitter. (A) Invasion of a presynaptic terminal by a single action potential (1) causes brief opening of voltage-gated Ca 2+ channels (2) and a local increase in Ca 2+ concentration. One or more nearby small vesicles may fuse with the presynaptic membrane (3) and discharge their contents into the synaptic cleft; they are then recycled (4) in the synaptic terminal. (B) Repetitive action potentials (1) cause opening of more voltage-gated Ca 2+ channels for longer periods (2) and a correspondingly more widespread increase in Ca 2+ concentration. This causes fusion not only of small vesicles docked at active zones (3) but also of larger vesicles away from active zones (4).

Because neurotransmitter release is dependent on the entry of Ca 2+ , the modulation of the voltage-gated calcium channels can have a large physiological response. Several toxins as well as several drugs have been known to modulate these channels to inhibit or increase neuronal activity. In addition, there are known toxins, such as botulinum toxin, that interfere with the ability of the acetylcholine-containing vesicles, inhibiting their release, and resulting in the relaxation of skeletal muscles (see Box 8.1 ).

Neurotransmitters Diffuse Across the Synaptic Cleft and Bind to Postsynaptic Receptors

Neurotransmitters released from small vesicles find postsynaptic receptor molecules waiting for them directly across the synaptic cleft ( Fig. 8.7 ). For this reason, it takes the contents of such vesicles very little time to exert their effects. The total synaptic delay from presynaptic action potential to postsynaptic effect can be less than 200 µsec. The contents of large vesicles, in contrast, take longer to be released and often diffuse to receptors relatively far away (see Fig. 8.9 ), so their effects develop more slowly. As a self-regulation of transmitter release, at times the presynaptic neuron will also contain receptors (autoreceptors) that often result in the slowing of neurotransmitter release.

Fig. 8.7, Juxtaposition of presynaptic voltage-gated Ca 2+ channels and postsynaptic neurotransmitter receptors, shown at a neuromuscular junction by using toxins coupled to fluorescent dyes. The area of a frog neuromuscular junction outlined in (A) is enlarged in (B) and (C). (B) A marine snail toxin (ω-conotoxin) that binds selectively to voltage-gated Ca 2+ channels demonstrates these channels’ locations in the presynaptic terminal. (C) Staining the same area with a snake toxin (α-bungarotoxin) that binds to nicotinic acetylcholine receptors (the type found at neuromuscular junctions) demonstrates that these receptors have an almost exactly parallel distribution in the postjunctional muscle membrane.

Neurotransmitter Action Is Terminated by Uptake, Degradation, or Diffusion

Neurotransmitter molecules must be removed quickly once they have had a chance to bind to receptors so that the postsynaptic membrane will be prepared for subsequent releases of transmitter. This is accomplished by almost every means imaginable ( Fig. 8.8 ). Binding of neurotransmitter and receptor is a reversible event, so receptors and removal mechanisms compete for transmitter. Some transmitter simply diffuses away, but this is a slow process. In most synapses, transmitter is reabsorbed into the presynaptic ending or taken up by neighboring glial cells or even by the postsynaptic neuron. In some synapses, enzymes in the synaptic cleft degrade free transmitter. Reabsorbed transmitters or their metabolic products, like vesicle membranes, are often recycled for use in a subsequent synaptic event.

Fig. 8.8, Neurotransmitter binds to postsynaptic receptors (1) while other mechanisms compete for the transmitter, trying to remove it from the synaptic cleft. Although it is unlikely that all these mechanisms would be used at a single synapse, different synapses use various combinations of reuptake of neurotransmitter by the presynaptic terminal (2) or nearby glial cells (3), enzymatic inactivation of neurotransmitter (4), and uptake by the postsynaptic terminal (5). Finally, some neurotransmitter simply diffuses out of the synaptic cleft (6).

Different kinds of neurotransmitters have different preferred mechanisms of removal. For example, serotonin, norepinephrine, and dopamine are transported rapidly back into the presynaptic ending through large protein transporters for repackaging into synaptic vesicles. Acetylcholine, in contrast, is split into acetate and choline by acetylcholinesterase in the synaptic cleft; the choline is then transported back into the presynaptic ending and used for the resynthesis of more acetylcholine. Neuropeptides are either degraded by extracellular peptidases or swallowed up by the postsynaptic cell while still attached to their receptors ( Fig. 8.9 ).

Fig. 8.9, Endocytotic removal of a neuropeptide (substance P) and its receptor by postsynaptic neurons, demonstrated by staining substance P receptors using a fluorescent antibody technique. In the absence of stimulation, substance P receptors coat the somatic and dendritic membranes of pain-sensitive second-order neurons in the spinal cord posterior horn (A, red and yellow fluorescence ), and the distal dendrites of these cells have a uniform diameter (B). Five minutes after a painful stimulus on the ipsilateral side, most of the substance P receptor has left the surface membranes and is found intracellularly (C), and distal dendrites have a beaded appearance, with varicosities filled with endosomes containing substance P receptor (D). Over about the next hour, the internalized substance P receptor molecules are recycled to the cell surface. The scale mark in (A) (also applies to [C]) is 20 µm. The scale mark in (B) (also applies to [D]) is 10 µm.

Synaptic Transmission Can Be Rapid and Point-to-Point, or Slow and Often Diffuse

Postsynaptic events in response to transmitter-receptor binding fall into two general categories: fast and slow. Some postsynaptic responses involve electrically silent metabolic or membrane changes, but most involve depolarizing or hyperpolarizing potential changes across the postsynaptic membrane. A depolarizing response brings the postsynaptic element closer to its threshold for firing an action potential and so is referred to as an excitatory postsynaptic potential (or EPSP ). Conversely, a hyperpolarizing response moves the membrane away from the threshold and so is referred to as an inhibitory postsynaptic potential (or IPSP ). Hence there are fast and slow EPSPs, and fast and slow IPSPs.

Fast synaptic potentials are used for point-to-point transfer of specific bits of information: for example, by motor neurons projecting to particular muscle fibers or by tract cells projecting to particular parts of the thalamus (e.g., see Fig. 10.19 ). Slow synaptic potentials are sometimes used in this way too, but many are generated by diffusely projecting neurons with hundreds of branches that regulate the overall activity level of broad expanses of the nervous system (e.g., see Fig. 11.24, Fig. 11.26, Fig. 11.27, Fig. 11.28 ).

Rapid Synaptic Transmission Involves Transmitter-Gated Ion Channels

Early studies of synaptic transmission demonstrated that a single action potential in the motor nerve ending at a neuromuscular junction causes a large but brief EPSP, c

c Often referred to as an end-plate potential because motor end plate is another term for neuromuscular junction.

sufficient to cause an action potential and contraction in the muscle fiber ( Fig. 8.10B ). Closer analysis revealed small, brief depolarizing events in the postjunctional muscle membrane during the periods between action potentials (see Fig. 8.10A ), each corresponding to a brief period of channel opening and depolarizing current flow. We now know that each of these small depolarizing events is the response of the postsynaptic membrane to the spontaneous release of one synaptic vesicle. Each vesicle contains about 10,000 acetylcholine molecules, which diffuse across the synaptic cleft and bind briefly to acetylcholine receptors, which are ligand-gated ion channels permeable to Na + and K + ions. Acetylcholinesterase competes with the receptors for the released acetylcholine, so the channels stay open for only a millisecond or two. During this time, they allow a current flow that tries to move the membrane potential to a value around 0 mV (between the Na + and K + equilibrium potentials; see Chapter 7 , Calculating the Membrane Potential, Eq. 7.17 ). Because 2 msec is considerably less than the time constant of the muscle membrane, the membrane potential never reaches 0 mV. Instead, it rises rapidly at the beginning of the postsynaptic current flow and then decays slowly at the end of the current flow (see Fig. 8.10A ). Entry of depolarizing current is localized to the site of the receptors, so the postsynaptic potential decays electrotonically (see Fig. 8.10C and D ). However, the presynaptic ending at each neuromuscular junction contains more than 1000 active zones ( Fig. 8.11 and see Fig. 8.7 ), so a single action potential in the motor axon causes the nearly simultaneous release of hundreds of vesicles full of acetylcholine at closely spaced sites, which in turn causes the large EPSP normally seen (see Fig. 8.9B ).

Fig. 8.10, Intracellular recordings of muscle membrane potential at the motor end plate of a frog muscle fiber (A and B) and about 2 mm away from the end plate (C and D), demonstrating the localization of postjunctional potentials to the region of the neuromuscular junction. At rest, small depolarizing events (referred to as miniature end-plate potentials), each corresponding to the release of a single acetylcholine-filled vesicle, can be recorded at the end plate (A). At a point 2 mm away, they have almost completely died out because of electrotonic spread (C). An action potential in the motor axon elicits a large postjunctional potential at the end plate (B; note the different time and voltage scale), rapidly reaching threshold (arrow) and triggering a muscle action potential. At 2 mm away (D), only the propagated action potential remains.

Fig. 8.11, Three-dimensional structure of a neuromuscular junction. This scanning electron micrograph shows a motor axon (A) approaching a muscle fiber (M) in a calf muscle (peroneus longus) of a hamster. The axon divides into a series of terminal branches that occupy grooves in the surface of the muscle fiber. Removing these branches from a similar neuromuscular junction reveals a series of troughs traversing the grooves, each corresponding to one of the troughs in Fig. 8.1 and containing acetylcholine receptors. The actual size of the end plate is about 7 × 12 µm.

The basic elements of neuromuscular transmission have proved to be generally true of fast synaptic transmission throughout the nervous system ( Fig. 8.12A ). Depolarization-induced Ca 2+ entry causes the release of one or more packets of neurotransmitter, called quanta, each of which is generally assumed to be the contents of a single vesicle docked at an active zone. The neurotransmitter then diffuses across the synaptic cleft and binds transiently to a transmitter-gated (i.e., ligand-gated) ion channel. The selectivity of the channel determines the postsynaptic effect. Opening channels selective for monovalent cations, as in the example of the neuromuscular junction, causes an EPSP. In contrast, opening channels selective for Cl moves the membrane potential toward the Cl equilibrium potential; this is the most common basis of fast IPSPs in the central nervous system (CNS). The selective concentration of receptors on the postsynaptic membrane ensures that fast postsynaptic potentials are localized spatially. Transmitter-gated ion channels are also referred to as ionotropic receptors (from the same Greek word that gave rise to tropism, a movement toward or away from a stimulus, as in the heliotropic growth of plants in the direction of sunlight).

Fig. 8.12, Basic events in typical fast (A) and slow (B) synaptic transmission. (A) At rest, ligand-gated ion channels (ionotropic receptors) in the postsynaptic membrane are closed (1), and vesicles are docked in the presynaptic terminal (2) awaiting release. Depolarization of the terminal (3) causes Ca 2+ influx (4), transmitter exocytosis, binding of transmitter to postsynaptic ligand-gated ion channels (5), and opening of the channels. In this example, open channels allow Na + influx (6) and K + efflux (7), depolarizing the postsynaptic membrane. (B) Most slow synaptic responses involve metabotropic receptors (1) coupled at rest to a three-subunit G protein (2), as well as transmitters in large, dense-core vesicles (3) or in certain small vesicles. Prolonged or repetitive depolarization (4) of the presynaptic terminal causes widespread Ca 2+ influx (5), exocytosis of transmitter from large, dense-core vesicles (6), and binding to G protein–coupled receptors (some of which may be located some distance from the presynaptic terminal; see Fig. 8.9 ). This binding causes dissociation of the G protein into subunits (7), which can have a variety of effects. They may bind to ion channels and alter their conductance (8); activate an enzyme (9), which in turn alters the concentration of a second messenger (e.g., cyclic adenosine monophosphate, inositol triphosphate, arachidonic acid metabolites); or have even more complex effects (10), such as altering gene expression.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here